Literature DB >> 24139358

Pain management practice patterns for common pediatric urology procedures.

Kasey Morrison1, Katherine Herbst2, Sean Corbett3, C D Anthony Herndon3.   

Abstract

OBJECTIVE: To characterize practice patterns among members of the Society for Pediatric Urology.
METHODS: A survey instrument assessing pain management was e-mailed to all members of the Society for Pediatric Urology. Five hundred fifteen invitations were sent, 134 were included, for a 26% response rate. Pain management strategies were assessed for 7 case scenarios. Surveys were included if the responder answered a minimum of 2 case scenarios. Question Pro survey engine was used to process the survey.
RESULTS: Local/regional block was the most frequent intraoperative anesthesia (54%-90%). Epidural/caudal use varied from 19% to 42%. For postop opioids, a dichotomy exists between those without age restriction and those who wait until the patient is 6 months old. Sixty three percent responded that ketorolac was prescribed only if the patient had normal renal function, 20% after confirmation of adequate urine output for bilateral procedures, 3% when postoperative creatinine was normal, and 14% did not use ketorolac at all. In regards to age limitations, most did not indicate a limit (53%), whereas a large number required the child to be older than 6 months (26%). Regarding local blocks, most urologists perform the block themselves (61%) for simple/complex penile surgery or inguinal surgery. Of this group, only 33% actually bill for the administration of the block. After a caudal block, a minority (26%) of respondents require the patient to void before discharge for ambulatory procedures.
CONCLUSION: There is no clear consensus in pain management for common pediatric urologic procedures. These disparities should be the aim of future studies.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24139358     DOI: 10.1016/j.urology.2013.08.041

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  6 in total

1.  Pediatric Urologic Surgery: Reducing Opioid Use.

Authors:  Ryan Nelson; Tim Shimon; Gwen M Grimsby
Journal:  Paediatr Drugs       Date:  2021-07-31       Impact factor: 3.022

2.  Use of Caudal Analgesia Supplemented with Low Dose of Morphine in Children Who Undergo Renal Surgery.

Authors:  Boris Chertin; Alexander Zeldin; Stanislav Kocherov; Alexander Ioscovich; Israel A Ostrovsky; Yaacov Gozal
Journal:  Curr Urol       Date:  2016-09-20

3.  The role of ultrasound guidance in pediatric caudal block.

Authors:  Koray Erbüyün; Barış Açıkgöz; Gülay Ok; Ömer Yılmaz; Gökhan Temeltaş; İdil Tekin; Demet Tok
Journal:  Saudi Med J       Date:  2016-02       Impact factor: 1.484

4.  The combinatorial use of propofol-fentanyl-ketamine for sedoanalgesia in patients undergoing urological procedures.

Authors:  Abdelkarim S Aloweidi; Sami A Abu-Halaweh; Ghazi M Al-Edwan; Saddam H Al Demour; Laith T Abu Mahfuz; Osama N Noubani; Mohammad M Al Rwaidi; Isam K Bsisu; Mohammad M Abufaraj
Journal:  Saudi Med J       Date:  2021-06       Impact factor: 1.422

Review 5.  Guidelines for Opioid Prescribing in Children and Adolescents After Surgery: An Expert Panel Opinion.

Authors:  Lorraine I Kelley-Quon; Matthew G Kirkpatrick; Robert L Ricca; Robert Baird; Calista M Harbaugh; Ashley Brady; Paula Garrett; Hale Wills; Jonathan Argo; Karen A Diefenbach; Marion C W Henry; Juan E Sola; Elaa M Mahdi; Adam B Goldin; Shawn D St Peter; Cynthia D Downard; Kenneth S Azarow; Tracy Shields; Eugene Kim
Journal:  JAMA Surg       Date:  2021-01-01       Impact factor: 14.766

6.  Effectiveness of analgesia with hydromorphone hydrochloride for postoperative pain following surgical repair of structural congenital malformations in children: a randomized controlled trial.

Authors:  Yongying Pan; Yimin Wang; Dongxu Lie; Di Liu; Xi Chen; Zeyan Wu; Liumei Chen; Huaizhen Wang; Liangming Peng; Huiying Liang; Xingrong Song; Baisong Zhao
Journal:  BMC Anesthesiol       Date:  2021-07-16       Impact factor: 2.217

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.